Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Alla S. Lisyanskaya"'
Autor:
Ana Oaknin, Bradley J. Monk, Ignace Vergote, Andreia Cristina de Melo, Yong-Man Kim, Alla S. Lisyanskaya, Vanessa Samouëlian, Hee Seung Kim, Evgeniy A. Gotovkin, Fernanda Damian, Chih-Long Chang, Shunji Takahashi, Jingjin Li, Melissa Mathias, Matthew G. Fury, Cristina Ivanescu, Matthew Reaney, Patrick R. LaFontaine, Israel Lowy, James Harnett, Chieh-I Chen, Krishnansu S. Tewari
Publikováno v:
Scientia
Chemotherapy; Quality of life; Symptoms Quimioterapia; Calidad de vida; Síntomas Quimioteràpia; Qualitat de vida; Símptomes Background In a phase III, randomised, active-controlled study (EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9; R2810-ONC-1676; NCT0
Autor:
Hani Gabra, Tarek M. Meniawy, Prashanth Gopalakrishna, Euan A. Stronach, Eleni Frangou, Michelle DeSilvio, Alla S. Lisyanskaya, Jeffrey C. Goh, Marcia Hall, Agnieszka Michael, Shirley Wong, Linda Mileshkin, Anne L. Hamilton, Sarah P. Blagden
Study treatment disposition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6928111c7af9ae5058e202fc9fa1fd8
https://doi.org/10.1158/1078-0432.22471176
https://doi.org/10.1158/1078-0432.22471176
Autor:
Hani Gabra, Tarek M. Meniawy, Prashanth Gopalakrishna, Euan A. Stronach, Eleni Frangou, Michelle DeSilvio, Alla S. Lisyanskaya, Jeffrey C. Goh, Marcia Hall, Agnieszka Michael, Shirley Wong, Linda Mileshkin, Anne L. Hamilton, Sarah P. Blagden
Adverse events
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52397cae5f9e323204a143cd7e6f50f3
https://doi.org/10.1158/1078-0432.22471170
https://doi.org/10.1158/1078-0432.22471170
Autor:
Hani Gabra, Tarek M. Meniawy, Prashanth Gopalakrishna, Euan A. Stronach, Eleni Frangou, Michelle DeSilvio, Alla S. Lisyanskaya, Jeffrey C. Goh, Marcia Hall, Agnieszka Michael, Shirley Wong, Linda Mileshkin, Anne L. Hamilton, Sarah P. Blagden
Purpose:Preclinically, AKT kinase inhibition restores drug sensitivity in platinum-resistant tumors. Here the pan-AKT kinase inhibitor afuresertib was given in combination with paclitaxel and carboplatin (PC) in patients with recurrent platinum-resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00425bc8f0dd54463499f019dc388f02
https://doi.org/10.1158/1078-0432.c.6527799.v1
https://doi.org/10.1158/1078-0432.c.6527799.v1
Autor:
Hani Gabra, Tarek M. Meniawy, Prashanth Gopalakrishna, Euan A. Stronach, Eleni Frangou, Michelle DeSilvio, Alla S. Lisyanskaya, Jeffrey C. Goh, Marcia Hall, Agnieszka Michael, Shirley Wong, Linda Mileshkin, Anne L. Hamilton, Sarah P. Blagden
Summary of exposure to afuresertib, paclitaxel and carboplatin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f0f0a66cd70779c55a4e938f053fa7
https://doi.org/10.1158/1078-0432.22471173.v1
https://doi.org/10.1158/1078-0432.22471173.v1
Autor:
Khristina B Kotiv, Alexey M. Belyaev, Georgiy M Manikhas, Anna Sidoruk, Evgeny N. Imyanitov, Anna P. Sokolenko, Galina I Mikhailiuk, Alla S Lisyanskaya, Laslo D Roman, Ekatherina A Nekrasova, Nikolay Mikaya, Tatyana Gorodnova, Alexandr O. Ivantsov, Nikolay Bondarev, Olga N Mikheyeva, K. D. Guseynov, Igor Berlev, Nataliya S Matveyeva
Publikováno v:
International Journal of Gynecologic Cancer. 28:1498-1506
ObjectivesCisplatin and mitomycin C exert high activity towards BRCA1-deficient cells. This study aimed to evaluate the efficacy of a combination of these drugs in hereditary BRCA1-associated ovarian cancer (OC).MethodsTwelve OC patients, who could n
Autor:
Ruslan Glushakov, Georgiy M Manikhas, Alla S Lisyanskaya, Ekaterina P Fadeeva, Natalia I Tapilskaya
Publikováno v:
Reviews on Clinical Pharmacology and Drug Therapy. 14:47-57
This review provides the current evidence of clinical studies on the effectiveness of endocrine therapy for breast cancer and endometrial cancer, including endometrial stromal sarcoma, by aromatase inhibitor (AI) III generation. The review presents d
Autor:
Tatyana V, Gorodnova, Khristina B, Kotiv, Alexandr O, Ivantsov, Olga N, Mikheyeva, Galina I, Mikhailiuk, Alla S, Lisyanskaya, Nikolay A, Mikaya, Konstantin D, Guseynov, Nikolay E, Bondarev, Nataliya S, Matveyeva, Ekatherina A, Nekrasova, Anna A, Sidoruk, Laslo D, Roman, Georgiy M, Manikhas, Alexey M, Belyaev, Anna P, Sokolenko, Igor V, Berlev, Evgeny N, Imyanitov
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society. 28(8)
Cisplatin and mitomycin C exert high activity towards BRCA1-deficient cells. This study aimed to evaluate the efficacy of a combination of these drugs in hereditary BRCA1-associated ovarian cancer (OC).Twelve OC patients, who could not be treated by
Autor:
Matti Aapro, Giada Rizzi, Richard J. Gralla, Alla S. Lisyanskaya, Snežana M. Bošnjak, Karin Jordan, Giorgia Rossi, Anna V. Alyasova, Marco Palmas, Paul J. Hesketh
Publikováno v:
Journal of geriatric oncology. 8(1)
OBJECTIVES Prevention of chemotherapy-induced nausea and vomiting is critical in older patients with cancer. NEPA is an oral fixed combination of netupitant 300mg, a new NK1 receptor antagonist (RA), and palonosetron 0.5mg, a pharmacologically distin